Beneficiaries and Boards
Beneficiaries
Leibniz-Institut für Molekulare Pharmakologie (FMP)
Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
Fundacio Privada Parc Cientific de Barcelona (PCB)
Institute of Molecular Genetics AS CR (IMG)
European Molecular Biology Laboratory – Outstation European Bioinformatics Institute (EMBL-EBI)
Institute for Molecular Medicine Finland (FIMM)
Forschungszentrum für Molekulare Medizin GmbH (CeMM)
Danmarks Tekniske Universitet (DTU)
Institute for Medical Biology – Polish Academy of Sciences (IMB)
Netherlands Cancer Institute (NKI)
Bundesministerium für Bildung und Forschung (BMBF)
Wissenschaftsgemeinschaft Gottfried Wilhelm Leibniz e.V. (WGL)
Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V. (HGF)
Centro Interdipartimentale Studi bio-molecolari ed applicazioni Industriali (CISI)
Max Delbrück Center for Molecular Medicine (MDC)
Institutul de Chemie Tomisoara al Academiei Romane (ICT)
The EU-OPENSCREEN Advisory Board
| NAME | AFFILIATION |
| Prof. Dr. Dr. h. c. Ernst Th. Rietschel | acatech |
| Prof. Dr. Ferran Sanz | Director, Research Programme on Biomedical Informatics at Institut Municipal d'Investigació Mèdica (IMIM) |
| Prof. Dr. Jan Olof Kihlberg | AstraZeneca |
| Dr. Serge Braun | Scientific Director, Association Française contre les Myopathies (AFM) |
The EU-OPENSCREEN Experts
| EXPERT GROUP | NAME | AFFILIATION | CONTACT |
| Industrial Expert | Philip Gribbon (Chair) | European ScreeningPort | Philip.Gribbon@screeningPort.com |
| Industrial Expert | Jeremy Everett | ex Pfizer, currently University of Greenwich | J.R.Everett@greenwich.ac.uk |
| Industrial Expert | Thierry Langer | Prestwick Chemical | Thierry.langer@prestwickchemical.fr |
| Industrial Expert | Steve Rees | AstraZeneca | steve.rees@astrazeneca.com |
| Industrial Expert | Ulrich Stilz | Sanofi Aventis | Ulrich.Stilz@sanofi-aventis.com |
| Open Access IP Expert | Reto M. Hilty | Max-Planck-Institute | hilty@ip.mpg.de |
| Open Access IP Expert | Kaya Köklü | Max-Planck-Institute | kaya.koeklue@ip.mpg.de |
| Open Access IP Expert | Franck Macrez | CEIPI | franck.macrez@ceipi.edu |
| Open Access IP Expert | John Hendrik Weitzman | iRights.law/Legal Project Lead at Creative Commons | j.weitzmann@irights-law.de |
| Chemical Diversity Expert | Michael Foley | Director of the Broad Institute's (USA) Chemical Biology Platform | mfoley@broadinstitute.org |
| Innovative Target and Assay Expert | Sir Philip Cohen | University of Dundee | p.cohen@dundee.ac.uk |
| Strategy Expert | James Inglese | National Institutes of Health (USA) | jinglese@mail.nih.gov |
